CHRYSTAL CAPITAL APPOINTED AS FINANCIAL ADVISOR TO IOFINA Plc.
Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has advised Iofina Plc.
“Iofina is a company that we know well and have followed since it first listed back in 2018. The underlying product has a seen a resurgence in value as the multitude of uses for iodine have come to the fore in an ever-increasing unstable World. We look forward to introducing the story to not only London based institutions but also a wide plethora of family offices from natural resources, industrials, and medical backgrounds.”
“We have known the Chrystal team for a significant number of years and they have been active supporters and investors. As Iofina enters the next phase of its growth story it is keen to re-engage with those institutional investors that may have once been keen on the story but also new sources of long-term capital who can support us through both acquisitions and organic growth”
About Iofina
Iofina plc is a vertically integrated Company that specializes in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. Through its commitment to technology development and investing in its people, Iofina successfully services markets around the globe via its business lines, Iofina Resources and Iofina Chemical.
Iofina Resources (“IR”) is the Group’s iodine production business which isolates iodine using the Group’s proprietary WET® IOsorb® technologies. Unlike other major US manufacturers, Iofina isolates iodine that is recovered from the brine produced from oil and gas operations that would otherwise be wasted. IR has become the second largest producer of iodine in North America, which currently imports a vast majority of its iodine. Iodine has numerous applications in human health, biocides, acetic acid manufacturing and many others. IR’s crystalline IOflo® iodine is either sold directly to global customers or converted to iodine based compounds at its sister company Iofina Chemical.
Established in 1983 and acquired by Iofina in 2009, Iofina Chemical (“IC”) is the Group’s technology focused, halogen-based specialty chemical producer. IC has and continues to invest heavily in researching and developing new iodo-, chloro-, and fluoro-based specialty compounds and provides the global market with quality iodine products, supported with strong, technical customer support.
For more information, see https://iofina.com/
About Chrystal Capital
Chrystal Capital is a corporate finance and investment house with an established global network of Single Family Offices, Ultra High Net Worth Individuals and private equity co-investment partners. We act as a conduit between our network members, providing bespoke solutions for their capital and investment objectives.
Our core sectors are Digital Economy, Health & Wellness, Sustainable & Impact Investments, and Natural Resources.
Our service areas are Advisory, Principal Investments and Co-investments.
For further information please contact:
Rak Karia
Director, Head of Natural Resources
raj.karia@chrystalcapital.com
https://www.chrystalcapital.com